What is the additional clinical value of using a hybrid capture-based NGS platform? Can you discuss in terms of false-negativity and sensitivity analyses?

What is the additional clinical value of using a hybrid capture-based NGS platform? Can you discuss in terms of false-negativity and sensitivity analyses?

What is the additional clinical value of using a hybrid capture-based NGS platform? Can you discuss in terms of false-negativity and sensitivity analyses?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Professor Nir Peled, MD, PhD, FCCP

Professor Nir Peled, MD, PhD, FCCP

Pulmonologist and Medical Oncologist
Thoracic Cancer Unit
Davidoff Cancer Center
Tiqwa, Israel